Changing drug supply

Last updated September 2025

Philadelphia’s drug supply is always changing. Opioids are the primary substance involved in fatal overdoses, but stimulants (like cocaine and meth), sedatives (like medetomidine and xylazine), and other adulterants are increasingly common in overdose deaths. PDPH partners with the Center for Forensic Science Research & Education (CFSRE) to monitor the local drug supply, which enables SUPHR to inform the public and area healthcare providers about the city’s substance use landscape. 

Philly’s drug supply at a glance: 

  • In 2023, 70% of opioid overdose deaths also involved a stimulant. Polysubstance use, or the use of a combination of different drugs at the same time or close together, can be on purpose, to change the experience or counter side effects, or by accident, like when drugs are mixed without the person knowing. 

  • In the past couple of years, multiple new drugs have been found in our drug supply, including carfentanil, BTMPS and nitazene analogs. Read more about them below.

SUPHR drug checking reports

Drug supply adulterants

Contaminants in Philly’s drug supply have made the environment more unpredictable and dangerous for people who use. The most common type of adulterant in the dope supply is sedatives - mainly medetomidine, but also xylazine - but other substances have become more common during the past couple of years. Read more about them below and download the community alert PDFs for each.

Connect With Us.

Sign up for SUPHR’s drug checking listserv by filling out the form below. Want to learn more? Check out our events calendar to register for upcoming trainings, print more materials from our materials library, view data on our data dashboard, and read recent substance use alerts and advisories.